DOLLY PARTON RETURNS TO PUBLIC EYE TO CELEBRATE OPENING DAY AT DOLLYWOOD . (PHOTO).

Image
 Dolly Parton returns to public eye to celebrate opening day at Dollywood     Dolly Parton made her first public appearance in months to celebrate the opening day of Dollywood in Pigeon Forge, Tennessee, on Friday. The country music icon reflected on the past year, a year after the death of her husband of nearly 60 years, Carl Dean, saying she is “doing good” and has been working to rebuild herself spiritually, emotionally, and physically after grieving and dealing with health issues that kept her from touring. Joined on stage by Dollywood president Eugene Naughton, Parton brought her trademark humor to the crowd, joking about rumors of a new husband while reaffirming her devotion to Dean. She also shared updates on her ongoing projects, including a new Broadway musical and her Dolly’s Life of Many Colors Museum in Nashville. Parton previewed the park’s 41st season, highlighting the upcoming NightFlight Expedition ride, a new “Run Dollywood” race weekend, an updated ...

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

AMBODE,SOYINKA & OTHERS AT THE OFFICIAL LAUNCH OF LAGOS AT 50 YEARS ANNIVERSARY AGAINST 2017.{PHOTOS}.